Holen Sie sich die Stockscreener-App
101.10
0.35%
0.35
Incyte Corp Aktie (INCY) Neueste Nachrichten
Incyte’s weak Opzelura 2026 revenue forecast heightens Jakafi patent concerns (Feb 10) By Reuters - Investing.com
Incyte Corporation $INCY Shares Sold by Sound Shore Management Inc CT - MarketBeat
LSV Asset Management Buys 124,266 Shares of Incyte Corporation $INCY - MarketBeat
Illinois Municipal Retirement Fund Sells 15,073 Shares of Incyte Corporation $INCY - MarketBeat
Do Wall Street Analysts Like Incyte Corporation Stock? - inkl
INCY: Stifel Raises Price Target to $120, Maintains Buy Rating | - GuruFocus
Incyte shifts course on downtown Wilmington project, sells Bracebridge buildings as state incentives face scrutiny - Delaware LIVE News
Incyte selling buildings and cutting back space at future downtown headquarters - Delaware Business Now
Incyte selling buildings and cut back space at future downtown headquarters - Delaware Business Now
Royal Bank Of Canada Cuts Incyte (NASDAQ:INCY) Price Target to $92.00 - MarketBeat
Incyte (INCY): RBC Capital Lowers Price Target to USD 92 | INCY Stock News - GuruFocus
Incyte (INCY) Analyst Ratings Update: Wells Fargo Lowers Price Target | INCY Stock News - GuruFocus
Wells Fargo & Company Cuts Incyte (NASDAQ:INCY) Price Target to $101.00 - MarketBeat
INCY Q4 Deep Dive: Revenue Growth Outpaces Profit as Pipeline Advances, Margins Narrow - Finviz
Incyte Corporation (NASDAQ:INCY) Q4 2025 Earnings Call Transcript - Insider Monkey
INCY: HC Wainwright & Co. Reiterates Buy Rating, Maintains $135 Price Target | INCY Stock News - GuruFocus
Incyte Faces Growing Pains As It Looks To Build Post-Jakafi Foundation - Citeline News & Insights
Incyte Shares Surge on Strong Revenue Performance and Pipeline Progress - AD HOC NEWS
Incyte Faces Jakafi Patent Cliff; Focus on Opzelura and Advancing Pipeline to Offset Losses - Morningstar
Decoding Incyte Corp (INCY): A Strategic SWOT Insight - GuruFocus
Incyte: Fourth Quarter Earnings Overview - Bitget
Incyte (INCY) Shares Fall After Q4 Earnings Miss and Weak 2026 O - GuruFocus
Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance - AlphaStreet News
Incyte Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Incyte (INCY) Reports Strong Q4 and Annual Revenue Growth - GuruFocus
Incyte Q4 Earnings Call Highlights - Yahoo Finance
Incyte Corp (INCY) Q4 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Incyte (INCY) Shares Fall After Q4 Earnings Miss and Weak 2026 Outlook - GuruFocus
Jefferies reiterates Buy rating on Incyte stock, maintains $120 price target - Investing.com Canada
Why Incyte (INCY) Stock Is Nosediving - Finviz
INCY Q4 Earnings Miss Estimates, Revenues Beat on Higher Product Sales - sharewise.com
Incyte (INCY) Releases Product Revenue and Expense Guidance for 2026 - GuruFocus
Incyte (NASDAQ:INCY) Shares Gap Down Following Weak Earnings - MarketBeat
Truist Securities reiterates Hold rating on Incyte stock, maintains $103 target - Investing.com
Incyte Q4 2025 slides: Revenue surges 28%, stock dips on EPS miss - Investing.com
Incyte (INCY) Q4 2025 Earnings Call Transcript - The Globe and Mail
Incyte (INCY) Faces Challenges with Opzelura as Jakafi Patent Expiry Looms - GuruFocus
Earnings call transcript: Incyte’s Q4 2025 revenue beats estimates, stock dips - Investing.com
Incyte (INCY) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Incyte (NASDAQ:INCY) Posts Quarterly Earnings Results, Misses Estimates By $0.16 EPS - MarketBeat
Incyte (NASDAQ:INCY) Surprises With Q4 CY2025 Sales - Finviz
Incyte (INCY) Reports Strong Q4 Revenue and Promising Pipeline G - GuruFocus
Incyte Corp. (NASDAQ:INCY) Reports Mixed Q4 2025 Results with Revenue Beat and EPS Miss - ChartMill
Incyte (INCY) Q4 Earnings Lag Estimates - Yahoo Finance
Incyte weak 2026 revenue forecast heightens Jakafi patent concerns - Reuters
Incyte: Q4 Earnings Snapshot - kens5.com
Incyte (INCY) Q4 Revenue Surpasses Estimates Despite EPS Miss - GuruFocus
Incyte shares fall as Q4 earnings miss overshadows revenue beat - Investing.com
Incyte shares fall as Q4 earnings miss overshadows revenue beat By Investing.com - Investing.com South Africa
Incyte earnings missed by $0.11, revenue topped estimates - Investing.com
Incyte earnings missed by $0.11, revenue topped estimates By Investing.com - Investing.com South Africa
Incyte Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView
Earnings Breakdown: Incyte Q4 - Benzinga
Why Incyte (NASDAQ:INCY) Appears in Nasdaq Composite Index Coverage? - Kalkine Media
A Look Ahead: Incyte's Earnings Forecast - Benzinga
Will These 5 Drug Bigwigs Surpass Q4 Earnings Forecasts? - Yahoo Finance
Incyte earnings up next: Can pipeline ease Jakafi reliance? - Investing.com
Incyte earnings up next: Can pipeline ease Jakafi reliance? By Investing.com - Investing.com UK
Here's Why Incyte (INCY) is a Strong Value Stock - Yahoo Finance
Incyte (INCY) Q4 Earnings: What To Expect - Finviz
Thrivent Financial for Lutherans Purchases 39,660 Shares of Incyte Corporation $INCY - MarketBeat
Piper Sandler Raises Incyte (INCY) Price Target to $110 | INCY S - GuruFocus
Incyte sets February 10 call to unveil Q4 and full-year 2025 results - MSN
Incyte Gears Up to Report Q4 Earnings: Is a Beat in the Cards? - Finviz
0.87%
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):